Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T, Pellizzoni C, Jannuzzo MG, Poggesi I. Denolle T, et al. Among authors: jannuzzo mg. Clin Pharmacol Ther. 1999 Sep;66(3):282-7. doi: 10.1016/S0009-9236(99)70036-6. Clin Pharmacol Ther. 1999. PMID: 10511064 Clinical Trial.
Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma.
Sarapa N, Britto MR, Speed W, Jannuzzo M, Breda M, James CA, Porro M, Rocchetti M, Wanders A, Mahteme H, Nygren P. Sarapa N, et al. Cancer Chemother Pharmacol. 2003 Nov;52(5):424-30. doi: 10.1007/s00280-003-0685-x. Epub 2003 Aug 6. Cancer Chemother Pharmacol. 2003. PMID: 12904897 Clinical Trial.
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors.
Caponigro F, Lorusso D, Fornari G, Barone C, Merlano M, Airoldi M, Schena M, MacArthur R, Weitman S, Jannuzzo MG, Crippa S, Fiorentini F, Petroccione A, Comis S. Caponigro F, et al. Among authors: jannuzzo mg. Cancer Chemother Pharmacol. 2010 Jul;66(2):389-94. doi: 10.1007/s00280-009-1175-6. Epub 2009 Nov 22. Cancer Chemother Pharmacol. 2010. PMID: 20480279 Clinical Trial.
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Schöffski P, Besse B, Gauler T, de Jonge MJ, Scambia G, Santoro A, Davite C, Jannuzzo MG, Petroccione A, Delord JP. Schöffski P, et al. Among authors: jannuzzo mg. Ann Oncol. 2015 Mar;26(3):598-607. doi: 10.1093/annonc/mdu566. Epub 2014 Dec 8. Ann Oncol. 2015. PMID: 25488684 Free article. Clinical Trial.
17 results